Department of Health

New Wording: 1. Copies of any correspondence received by the department, from MSD, Pfizer, Eli Lilly, AbbVie, Johnson & Johnson, Novo Nordisk, Novartis, AstraZeneca, Roche, the Irish Pharmaceutical Healthcare Association, European Federation of Pharmaceutical Industries and Associations, related to the EU general pharma legislation/changes to regulatory data protection, competitiveness, between 20th January and 23rd May 2025. 2. Minutes of any meetings between department officials and MSD, Pfizer, Eli Lilly, AbbVie, Johnson & Johnson, Novo Nordisk, Novartis, AstraZeneca, Roche, the Irish Pharmaceutical Healthcare Association, European Federation of Pharmaceutical Industries and Associations, related to the EU general pharma legislation/changes to regulatory data protection, between 20th January and 23rd May 2025. (To clarify, point 2 for minutes of meetings would also cover meetings attended by the Minister) 3. Correspondence between the Department and the Department of the Taoiseach, or Department of Enterprise, related to the EU general pharma legislation/changes to regulatory data protection, between 1st March and 23rd May 2025. 4. Correspondence within the department, related to the EU general pharma legislation/changes to regulatory data protection, between 1st May and 23rd May 2025.